echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Two cold medicine stop production, stop using! Lizhu responded

    Two cold medicine stop production, stop using! Lizhu responded

    • Last Update: 2018-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the State Food and Drug Administration issued the "notice on stopping the production and sale of the pseudoephedrine tablets and Trojan pseudoephedrine Capsules" The two cold medicines, the pseudoephedrine tablets and Trojan pseudoephedrine capsules, were stopped and stopped production from now on In the announcement issued by the State Food and Drug Administration on November 30, it was said that after the reevaluation organized by the State Food and drug administration, it was believed that there were adverse effects of cardiotoxicity in the pseudoephedrine tablets and Trojan pseudoephedrine capsules, and the risk of use was greater than the benefit, so it was decided to stop the production, sale and use of the pseudoephedrine tablets and Trojan pseudoephedrine capsules in China from now on, and cancel the relevant drug approval documents According to the State Food and drug administration, the manufacturers are responsible for recalling the marketed pseudoephedrine tablets and Trojan pseudoephedrine capsules, which shall be completed before December 31, 2018, and the recalled products shall be destroyed under the supervision of the local drug administration In response to this, on December 4, Lizhu Pharmaceutical Co., Ltd issued the announcement of Lizhu Pharmaceutical Group Co., Ltd on the description of the pseudoephedrine tablets, saying that Lizhu pharmaceutical factory, a wholly-owned subsidiary of the company, was approved to produce the pseudoephedrine tablets in 1994 (approval No.: gyzz h10940182) and in December 2013 It has been stopped production since January, and the validity of the pseudoephedrine tablets is two years There is no recall The full text of the announcement is as follows:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.